Xcout Intel
Caldera Therapeutics
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Subscribe to see Caldera Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Caldera Therapeutics at a glance
Caldera Therapeutics is a drug discovery company headquartered in United States. Its most recent funding round, Series A, raised $75M in January 2026. Xcout tracks 6 named people at Caldera Therapeutics, including Praveen Tipirneni (Chief Executive Officer).
Caldera Therapeutics leadership
- Praveen TipirneniChief Executive Officer
- Praveen TipirneniExecutive Officer
- Aaron RoystonDirector
- Michael GladstoneDirector
- Michelle DoigDirector
- Xiaodi SuDirector
Caldera Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $75M | 6 named | |
| Series A-1 | $75M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Caldera Therapeutics news
Investors
Caldera Therapeutics competitors
A few of Caldera Therapeutics's closest competitors — see the full list of competitors and alternatives →
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Get Caldera Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Caldera Therapeutics in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access